Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Winston KungDirector | Corbus Pharmaceuticals HoldingsCRBP | Open-market sale10b5-1 plan | 06/10 | 06/11 | 2,026 sh | $7.91 | $16,025.66 | −14.3% |
John Kenneth JenkinsDirector | Corbus Pharmaceuticals HoldingsCRBP | Open-market sale10b5-1 plan | 06/10 | 06/11 | 4,800 sh | $7.91 | $37,968 | −55.6% |
Anne AltmeyerDirector | Corbus Pharmaceuticals HoldingsCRBP | Open-market sale10b5-1 plan | 06/10 | 06/11 | 2,412 sh | $7.91 | $19,078.92 | −24.1% |
Corbus Pharmaceuticals HoldingsCRBP | Open-market buy | 06/02–06/03 | 06/03 | 13,500 sh2 trades | $7.50avg. | $101,205 | +21.8% | |
Smethurst DominicChief Medical Officer | Corbus Pharmaceuticals HoldingsCRBP | Open-market sale | 03/02 | 03/04 | 6,097 sh | $8.30 | $50,605.1 | −6.4% |
Ian HodgsonCOO | Corbus Pharmaceuticals HoldingsCRBP | Open-market sale | 02/17 | 02/18 | 847 sh | $7.38 | $6,250.86 | −1.6% |
Corbus Pharmaceuticals HoldingsCRBP | Open-market sale10b5-1 plan | 02/13 | 02/18 | 4,701 sh | $7.78 | $36,573.78 | −4.6% | |
Cohen YuvalCEO | Corbus Pharmaceuticals HoldingsCRBP | Open-market sale10b5-1 plan | 02/13 | 02/18 | 13,871 sh | $7.78 | $107,916.38 | −7.4% |
Smethurst DominicChief Medical Officer | Corbus Pharmaceuticals HoldingsCRBP | Open-market sale | 02/03 | 02/04 | 3,285 sh | $8.09 | $26,575.65 | −3.3% |
Ian HodgsonCOO | Corbus Pharmaceuticals HoldingsCRBP | Open-market sale | 02/03 | 02/04 | 2,415 sh | $8.09 | $19,537.35 | −4.4% |
Cormorant Asset Management10% Owner | Corbus Pharmaceuticals HoldingsCRBP | Open-market sale | 25/12/11 | 25/12/15 | 30,029 sh | $11.46 | $344,132.34 | −1.3% |
Bihua Chen10% Owner | Corbus Pharmaceuticals HoldingsCRBP | Open-market sale | 25/12/11 | 25/12/15 | 30,029 sh | $11.46 | $344,132.34 | −1.3% |
Corbus Pharmaceuticals HoldingsCRBP | Open-market sale | 25/12/11 | 25/12/15 | 30,029 sh | $11.46 | $344,132.34 | −1.3% | |
Corbus Pharmaceuticals HoldingsCRBP | Open-market sale10b5-1 plan | 25/10/24–25/10/27 | 25/10/27 | 27,633 sh2 trades | $17.05avg. | $471,203.82 | −16.7% | |
Corbus Pharmaceuticals HoldingsCRBP | Open-market sale10b5-1 plan | 25/10/24 | 25/10/27 | 12,981 sh | $17.02 | $220,936.62 | −15.0% | |
Anne AltmeyerDirector | Corbus Pharmaceuticals HoldingsCRBP | Open-market sale10b5-1 plan | 25/10/20 | 25/10/21 | 1,060 sh | $20.50 | $21,730 | −14.6% |
John Kenneth JenkinsDirector | Corbus Pharmaceuticals HoldingsCRBP | Open-market sale10b5-1 plan | 25/05/30 | 25/06/02 | 2,783 sh | $7.35 | $20,455.05 | −98.8% |
Anne AltmeyerDirector | Corbus Pharmaceuticals HoldingsCRBP | Open-market sale10b5-1 plan | 25/05/30 | 25/06/02 | 1,392 sh | $7.25 | $10,092 | −50.0% |
Smethurst DominicChief Medical Officer | Corbus Pharmaceuticals HoldingsCRBP | Open-market sale | 25/03/06 | 25/03/07 | 6,393 sh | $6.78 | $43,344.54 | −8.3% |
Corbus Pharmaceuticals HoldingsCRBP | Open-market sale10b5-1 plan | 25/02/14 | 25/02/18 | 2,792 sh | $8.76 | $24,457.92 | −3.7% |